Medline (MDLN) Slips Amid Broader MedTech Weakness

Medline Inc. (NASDAQ:MDLN), a medical technology company manufacturing med-surg products, experienced a decline in its stock price amid broader weakness in the medtech sector. Parnassus Growth Equity Fund, an investment management firm, noted this trend in its second-quarter 2026 investor letter. The Fund reported that Medline Inc. shares fell 4.23% over the past month and 22.68% year-to-date, while the overall Russell 1000 Growth Index returned 16.74% for the quarter.

Despite this, Parnassus Growth Equity Fund remains constructively bullish on U.S. equities and continues to favor growth stocks. The company highlighted Medline Inc. in its Q2 2026 investor letter, stating that while the medical technology sector faced near-term concerns surrounding tariffs and higher transportation costs, the firm remains confident in Medline's long-term competitive positioning.